Follow-The-Filings

Security · featured owners

KURA Kura Oncology Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.3%
  • $1M
  • 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel reduce 0.25%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.25% Reduce −48.9% 120,568 $1M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $53.88M $67.48M
Net income -$152.63M -$173.98M -$278.67M
Net margin * — -322.9% -412.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $432.48M $744.83M $708.66M
Total non-current assets * $16.45M $15.33M $29.7M
Total assets $448.94M $760.16M $738.36M
Total current liabilities $35.26M $78.71M $116.97M
Total non-current liabilities * $16.4M $267.81M $447.25M
Total equity $397.27M $413.64M $174.14M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$124.82M $134.32M -$64.06M
Cash from investing $15.56M -$101.59M -$13.1M
Cash from financing $94.78M $154.42M $1.79M
Net change in cash -$14.48M $187.14M -$75.36M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders